PIK3CD and nonpapillary renal cell carcinoma: PIK3CD mRNA expression levels were associated with a favorable OS in stage III [HR 95% CI = 0.55 (0.31–0.96)], but a worse OS in stage IV [HR 95% CI = 2.42 (1.25–4.68)] patients with ccRCC.